These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17493386)

  • 21. Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.
    Zong L; Chen P; Wang DX
    World J Gastroenterol; 2014 Apr; 20(15):4440-5. PubMed ID: 24764685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of expression of CD138 and heparinase in hepatocellular carcinoma by tissue microarray].
    Lü ZL; Zhang WM; Xiao G; Zhang M; Xie D; Xu FP; Liang XJ; Bi SJ; Wen JM
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):82-6. PubMed ID: 16630481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
    Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma].
    Ou C; Wu FX; Luo Y; Cao J; Zhao YN; Yuan WP; Li Y; Su JJ
    Ai Zheng; 2005 Feb; 24(2):166-9. PubMed ID: 15694026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decoy receptor 3 is a prognostic factor in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
    Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of FADD in primary hepatocellular carcinoma and its relationship with hepatic apoptosis].
    Sun B; Wang B; Zhao X
    Zhonghua Gan Zang Bing Za Zhi; 2000 Feb; 8(1):37-9. PubMed ID: 10712784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increased level of Th17 cells in peripheral blood correlates with the development of hepatocellular carcinoma].
    Wang WW; Wang ZM; Liu YY; Qin YH; Shen Q
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):757-61. PubMed ID: 21163066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
    Chen G; Luo D
    Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
    Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
    Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
    Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
    Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
    Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressions of nucleoside diphosphate kinase (nm23) in tumor tissues are related with metastasis and length of survival of patients with hepatocellular carcinoma.
    An R; Meng J; Shi Q; Dai XX; Chen JH; Lei YJ; Shan B; Gao C; Chu YL; Dong XP
    Biomed Environ Sci; 2010 Aug; 23(4):267-72. PubMed ID: 20934113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.
    Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.